Buy
Sell
Share Name Share Symbol Market Type Share ISIN Share Description
AstraZeneca LSE:AZN London Ordinary Share GB0009895292 ORD SHS $0.25
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  +58.00p +0.91% 6,426.00p 6,425.00p 6,426.00p 6,467.00p 6,373.00p 6,373.00p 765,803 15:34:50
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 17,322.1 1,562.8 133.3 50.2 81,392.59

AstraZeneca 4Q Net Profit Fell; Sees Product Sales Growth in 2019

14/02/2019 7:57am

Dow Jones News


AstraZeneca (LSE:AZN)
Historical Stock Chart

2 Months : From Jan 2019 to Mar 2019

Click Here for more AstraZeneca Charts.

By Carlo Martuscelli

 

AstraZeneca PLC (AZN.LN) said Thursday that net profit in the fourth quarter decreased 21% on post-tax adjustments, and guided for product sales growth in the year ahead.

The Anglo-Swedish drug maker said net profit for the quarter ended Dec. 31 was $1.03 billion, compared with $1.30 billion the previous-year period. Revenue rose 11% to $6.42 billion, ahead of analysts' expectations of $6.32 billion, based on a FactSet consensus forecast. Core earnings per share, a closely-watched company measure that strips out exceptional items, rose 22% to $1.58, exceeding analyst expectations of $1.48.

A strong performance from its oncology portfolio buoyed product sales, which were up 8% at constant exchange rates in the period, the FTSE 100-listed company said.

Product sales in China rose 22% at constant exchange rates to $948 million in the quarter, the pharmaceutical company said. Chief Executive Pascal Soriot had previously singled out the region as a focus area, saying he saw the market eventually eclipsing the EU in size.

AstraZeneca said that in 2019 it sees product sales growing by a high single-digit percentage, and core EPS in the range of $3.50 and $3.70.

The company declared a dividend of $1.90 per share, taking the full-year dividend to $2.80.

 

Write to Carlo Martuscelli at carlo.martuscelli@dowjones.com

 

(END) Dow Jones Newswires

February 14, 2019 02:42 ET (07:42 GMT)

Copyright (c) 2019 Dow Jones & Company, Inc.

1 Year AstraZeneca Chart

1 Year AstraZeneca Chart

1 Month AstraZeneca Chart

1 Month AstraZeneca Chart
Your Recent History
LSE
AZN
AstraZenec..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:gb D:20190320 15:49:50